Type 1 diabetes trials in Brazil

In Brazil 9 Also abroad 539

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Belo Horizonte, Campinas, São Paulo
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Where
Belo Horizonte, Curitiba, Fortaleza, Goiânia, Marília, Rio de Janeiro, São Paulo
Age
1 year to 35 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Where
Campo Grande, Curitiba, Fortaleza, Goiânia, Marília, Porto Alegre, Ribeirão Preto, Rio de Janeiro, São Paulo, Vitória
Age
1 year to 35 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Belo Horizonte, Brasília, Campinas, Curitiba, Natal, Porto Alegre, Rio de Janeiro, São José dos Campos, São Paulo
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Curitiba, Fortaleza, Marília, Rio de Janeiro, São Paulo
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Aparecida de Goiânia, Belém, Bragança Paulista, Brasília, Campinas, Curitiba, Fortaleza, Goiânia, Manaus, Sao Jose Rio Preto, São Paulo, Uberlândia, Volta Redonda
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
No phaseTaking people
Efficacy and Safety of an Artificial Intelligence Tool for Carbohydrate Counting (Tiabete) in Children and Adults With Type 1 Diabetes Mellitus
Where
São Paulo
Age
6 years and over
People
50
Run by
University of Sao Paulo
See details and how to joinNCT07150052
No phaseNot yet taking people in Brazil
Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes
Where
Porto Alegre
Age
18 years to 65 years
People
27
Run by
Hospital de Clinicas de Porto Alegre
See details and how to joinNCT06934707
No phaseTaking people
Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor
Where
São Paulo
Age
21 years to 75 years
People
10
Run by
Glucotrack
See details and how to joinNCT06764069